Unexpectedly, the frequency of CD4+IL‐4+IL‐13+ Th2 cells (cluster 13) was significantly reduced in both CD and UC compared to control samples, suggesting that these cells may not play a major pathogenic role in the maintenance of chronic inflammation in therapy‐refractory IBD. The gene discussed is CD4; the disease is inflammatory bowel disease.